Thu, November 3, 2022

Hartaj Singh Maintained (UTHR) at Buy with Increased Target to $375 on, Nov 3rd, 2022

Hartaj Singh of Oppenheimer, Maintained "United Therapeutics Corporation" (UTHR) at Buy with Increased Target from $325 to $375 on, Nov 3rd, 2022.

Hartaj, nor any peers, have made any analyst calls on UTHR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30